Study description
A multicentric, prospective, randomize, longitudinal study: impact of the telemonitoring on therapeutic observance in patient with hematologic cancer treated with oral therapy.
Key results
First patient in: May 2025
Interventional • Clinical benefit
Clinical benefit
110
Patients enrolled in the program
3
Participating center(s) across the study
A multicentric, prospective, randomize, longitudinal study: impact of the telemonitoring on therapeutic observance in patient with hematologic cancer treated with oral therapy.
First patient in: May 2025